Mn Services Vermogensbeheer B.V. cut its position in shares of Equifax Inc. (NYSE:EFX – Free Report) by 2.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,200 shares of the credit services provider’s stock after selling 1,200 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Equifax were worth $13,870,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in EFX. QRG Capital Management Inc. acquired a new stake in shares of Equifax in the third quarter worth $313,000. Asset Management One Co. Ltd. increased its position in shares of Equifax by 0.5% during the third quarter. Asset Management One Co. Ltd. now owns 96,204 shares of the credit services provider’s stock valued at $28,271,000 after purchasing an additional 432 shares during the period. National Pension Service increased its holdings in Equifax by 4.5% in the 3rd quarter. National Pension Service now owns 166,004 shares of the credit services provider’s stock valued at $48,782,000 after buying an additional 7,107 shares during the period. Intact Investment Management Inc. acquired a new position in Equifax in the third quarter worth about $73,000. Finally, Northeast Investment Management bought a new position in shares of Equifax during the 3rd quarter worth approximately $224,000. 96.20% of the stock is currently owned by institutional investors and hedge funds.
Equifax Stock Up 0.1 %
Shares of NYSE:EFX opened at $264.69 on Tuesday. The company has a market capitalization of $32.81 billion, a price-to-earnings ratio of 58.82, a P/E/G ratio of 2.50 and a beta of 1.59. The business’s 50-day moving average is $289.99 and its 200-day moving average is $264.49. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.88 and a quick ratio of 0.88. Equifax Inc. has a 1 year low of $179.13 and a 1 year high of $309.63.
Equifax Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Tuesday, September 3rd were paid a $0.39 dividend. The ex-dividend date of this dividend was Tuesday, September 3rd. This represents a $1.56 dividend on an annualized basis and a yield of 0.59%. Equifax’s dividend payout ratio (DPR) is presently 34.67%.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the company. Robert W. Baird increased their price target on Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Bank of America boosted their target price on Equifax from $255.00 to $286.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. BNP Paribas upgraded Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 target price on the stock in a report on Thursday, September 19th. UBS Group initiated coverage on Equifax in a research report on Tuesday, October 1st. They issued a “buy” rating and a $360.00 target price on the stock. Finally, Stifel Nicolaus increased their price target on shares of Equifax from $265.00 to $305.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, Equifax has a consensus rating of “Moderate Buy” and a consensus target price of $310.47.
Get Our Latest Research Report on EFX
Insider Transactions at Equifax
In other Equifax news, EVP Carla Chaney sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total transaction of $845,550.00. Following the sale, the executive vice president now owns 10,875 shares in the company, valued at $3,065,118.75. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Equifax news, EVP Carla Chaney sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total value of $845,550.00. Following the completion of the sale, the executive vice president now owns 10,875 shares of the company’s stock, valued at $3,065,118.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John J. Kelley III sold 1,000 shares of Equifax stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $272.92, for a total value of $272,920.00. Following the completion of the transaction, the executive vice president now directly owns 11,269 shares in the company, valued at $3,075,535.48. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 62,304 shares of company stock worth $16,889,119 in the last quarter. Insiders own 1.57% of the company’s stock.
Equifax Company Profile
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Stories
- Five stocks we like better than Equifax
- Roth IRA Calculator: Calculate Your Potential Returns
- Intel: Is Now the Time to Be Brave?Â
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is a Special Dividend?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX – Free Report).
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.